Fidelity Investments
IMNM icon

Fidelity Investments’s Immunome IMNM Stock Holding History

Fidelity Investments’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371M Buy
16,969,954
+420,238
+3% +$9.35M 0.02% 624
2025
Q4 		$355M Buy
16,549,716
+3,493,007
+27% +$61.3M 0.02% 634
2025
Q3 		$153M Buy
13,056,709
+6,889,043
+112% +$68.5M 0.01% 969
2025
Q2 		$57.4M Buy
6,167,666
+2,275,348
+58% +$18.7M ﹤0.01% 1343
2025
Q1 		$26.2M Sell
3,892,318
-26,898
-0.7% -$258K ﹤0.01% 1591
2024
Q4 		$41.6M Sell
3,919,216
-305,484
-7% -$3.69M ﹤0.01% 1448
2024
Q3 		$61.8M Buy
4,224,700
+13,757
+0.3% +$195K ﹤0.01% 1288
2024
Q2 		$51M Sell
4,210,943
-323,700
-7% -$5.06M ﹤0.01% 1309
2024
Q1 		$112M Buy
4,534,643
+628,500
+16% +$12.8M 0.01% 1011
2023
Q4 		$41.8M Buy
+3,906,143
New +$32.5M ﹤0.01% 1358
2021
Q4 		– Sell
-32
Closed -$1K – 4655
2021
Q3 		$1K Sell
32
-226,424
-100% -$3.95M ﹤0.01% 4151
2021
Q2 		$3.92M Hold
226,456
– – ﹤0.01% 2401
2021
Q1 		$7.67M Sell
226,456
-113,900
-33% -$2.83M ﹤0.01% 2135
2020
Q4 		$3.29M Buy
+340,356
New +$3.97M ﹤0.01% 2290

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments's IMNM Position: Q1 2026 in Review

Fidelity Investments increased its Immunome (IMNM) stake by 2.5% in Q1 2026, buying an estimated $9.35M and bringing the position to 16,969,954 shares worth $371M. The position accounts for 0.02% of the portfolio, ranked #624.

Fidelity Investments first reported a position in IMNM in Q4 2020 and has held it in 14 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Fidelity Investments held 16,969,954 shares of Immunome worth $371M as of Q1 2026.
  • Fidelity Investments bought 420,238 Immunome shares in Q1 2026, an estimated $9.35M.
  • Immunome made up 0.02% of Fidelity Investments's portfolio in Q1 2026, its #624 holding.
  • Fidelity Investments first reported a position in Immunome in Q4 2020 and has held it in 14 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.